Moreover, we also explored the contribution of HHLA2 to pathogenesis and progression of human ccRCC, and further confirmed that HHLA2 was involved in the promotion of EMT during cancer progression. This evidence concerns the gene HHLA2 and nonpapillary renal cell carcinoma.